3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase NA
3
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Glioma
1
Gastrointestinal Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Basal Cell
1
Interventions
pembrolizumab
3
Oncolytic Virotherapy
3
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Radiotherapy
2
Nivolumab
2
Irinotecan
2
Doxorubicin
2
Cyclophosphamide
2
trastuzumab biosimilar HLX02
1
sodium thiosulfate
1
pertuzumab
1
perflutren
1
palbociclib
1
olaparib
1
niraparib
1
montelukast
1
eribulin
1
entrectinib
1
cobimetinib
1
camrelizumab
1
atezolizumab
1
apatinib
1
alovudine
1
alectinib
1
X-Rays
1
Vinorelbine
1
Vincristine
1
Vemurafenib
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Sarcoma
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled